surpass trial tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 LLY says #semaglutide Sustain-1 $NVO

Anandhanarayanan, A., Teh, K., Goonoo, M., Tesfaye, S

Lu, E., Wolfrey, F

Age is one factor, but lifestyle habits like smoking, drinking, and poor diet also play a big role

Slowed digestion is the main cause Ozempic slows down how quickly food moves through your digestive system, which can cause constipation, says Candice Sapp, RD

Furthermore, advanced research into ferroptosis mechanisms in CHD may identify novel targets and strategies for CHD prevention and treatment, potentially mitigating myocardial injury by inhibiting ferroptosis-related signaling pathways or enhancing antioxidant capacity, ultimately improving cardiac function and quality of life for CHD patients

Pricing is transparent and direct-pay, with no insurance processing required